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Nowadays, a laparoscopic surgery (LS) has become the cor-
nerstone of the minimally invasive surgery in gynecology not 
only for benign diseases but also for malignant diseases. It has 
such tempting merits that most surgeons are not able to resist 
its attractions. Comparing with open surgery (OS), the estab-
lished benefits of LS include incomparably much less post-
operative pain thanks to tiny wound, shorter hospital stays 
and subsequent medical cost decrease, less estimated blood 
loss (EBL) and reducing possibility of transfusion with less 
postoperative complications and comparable treatment out-
comes including survivals in selected cases. It has been found 
that laparoscopic pelvic lymphadenectomy was facilitated by 
the positive intraperitoneal pressure secondary to pneumo-
peritoneum, which helps dissect the pelvic spaces.1
To date, with/without pelvic or para-aortic lymphadenec-
tomy, laparoscopic radical hysterectomy for early stage cer-
vical cancers and staging operation including total laparo-
scopic hysterectomy (TLH) or laparoscopic-assisted vaginal 
hysterectomy (LAVH) for endometrial cancers are widely per-
formed by gynecologic oncologists in many centers across the 
globe.2 In addition, for adnexal pathology, even though the 
use of laparoscopy is relatively limited only for benign and ear-
ly stage malignant disease, the role of LS is considerable. The 
main reason why LS is not used in ovarian cancer as many as 
other gynecologic malignancy seems to be the disease pro-
gression pattern of ovarian cancer, which is sprayed and dis-
seminated in the whole abdominal and pelvic cavity rather 
than step-by-step pattern, and the best strategy of treatment, 
“optimal debulking,” which is not easy to accomplish by LS in 
advanced stage. 
Given this LS wave, the current issue printed one article 
about comparison laparoscopic versus conventional open sur-
gical staging procedure for endometrial cancer.3 It demon-
strated that LS in endometrial cancer is a safe and feasible 
therapeutic procedure with comparable progression free sur-
vival and overall survival, which was in agreement with most 
of previous studies.2,4-6 However, further multicenter rando-
mized trials were warranted at all these studies. Recently, the 
initial survival data from timely LAP2 study of the Gyneco-
logic Oncology Group (GOG) were just released at the 41st 
annual meeting of the Society of Gynecologic Oncologists 
(SGO).7 They confirmed the safety, feasibility and comparable 
survival rates of LS, which have been reported by the previous 
small, non-randomized studies before,1,8,9 and suggested LS 
for a standard of care for uterine cancer. 
We can make some critical remarks on this article as follows: 
the outcomes were the same as previously reported and did 
not contribute new information to the literature. This was not 
a randomized trial and not similar to patients outside of 
Korea, therefore, could not be generalized to other locations 
of practice. And it had clinician specific bias into the treat-
ment plan of individual patients. The hospital stay was ex-
plained by the placement of drains which a slow to be removed 
and was no longer a treatment standard in modern oncology 
practice worldwide. We acknowledge the lack of specificity 
and the limitations of this article as a retrospective study. 
Nevertheless, we thought this article had some meaning in 
not only that it was worth confirming the comparability of LS 
to OS in endometrial cancer staging operation but also that it 
would make many readers who were preparing retrospective 
studies think over how to overcome the limits of this kind of 
study design. When it comes to a surgical drain, of course it is 
not any more the recommendation in oncologic surgical treat-
ments and it could lengthen the hospital stay. However, it 
does not matter whether they placed drains or not in terms of 
the comparison results reliability, only if the usage were equal 
in both groups.
In fact, this study has several shortcomings. At first, as re-
searchers acknowledged, this study has a few limitations as a 
retrospective study. Small number of cases and non-random-
ization weaken its power and reliability like other previous ret-
rospective studies.1,10,11 This kind of study cannot be blinded 
as it is impossible to hide the type of surgery performed, either 
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from patients or from healthcare professionals.12 This in-
evitably introduces bias. If the healthcare workers know that 
a patient has undergone LS, they may well expect a faster re-
covery and organize care in a different way from that of patients 
treated by OS. This bias might be avoided in future inves-
tigations if postoperative care is standardized. Second, they 
did mention one more surgeons were in charge of LS and OS 
of the study patients. Surgical outcomes considerably depend 
on the surgeon’s skill and experience. Therefore, the hidden 
confounding effects are not to be eliminated even if all the pro-
cedures were the same between the two groups. Third, BMI of 
patients in OS group was higher than that of LS group, and 
high BMI patients were likely to undergo OS rather than LS. It 
could also distract the truth. Fourth, the mean follow-up time 
was short, 25 months (range, 12 to 45 months). However, it 
should be noted that the majority of recurrences of endometrial 
carcinoma occur within the first 2 years after diagnosis.13 
Thus, similar 2-year recurrence-free survival may suggest si-
milar long-term survival. Based on the data analyzed in this 
study, the surgical approach (LS vs. OS) does not appear to im-
pact the survival of women with early-stage endometrial carci-
noma significantly.
On the other hands, there could be some pitfalls in LS. After 
laparoscopic pelvic lymphadenectomy, residual tissue was 
once reported.14 Tumor implantation might be the concern as-
sociated with LS, however, if any, it was noted to be rare and 
no worry to preclude LS in the treatments.15 Lastly, Sonoda et 
al.16 from the Memorial Sloan-Kettering Cancer Center raised 
concerns regarding a high incidence of positive peritoneal cy-
tology among women with low-risk endometrial carcinoma 
who were treated with laparoscopy. These authors found that 
10.3% of the patients treated with LAVH had positive peri-
toneal cytology compared with 2.8% of the patients treated 
with laparotomy. The authors speculated that retrograde dis-
semination of tumor cells into the peritoneal cavity during the 
uterine manipulation performed during LAVH might have ac-
counted for this difference. However, the clinical significance 
of the higher positive peritoneal cytology reported among 
these patients is questionable. They found no significant sur-
vival difference between women with positive versus women 
with negative peritoneal cytology. 
There are many kinds of other cancers in which endoscopic 
surgery is preferred to conventional OS, especially for early 
stage diseases, for example, cervical cancers,17,18 colorectal can-
cers,19,20 gastric cancers,21,22 urologic cancers including renal 
cell carcinomas and prostate cancers,23,24 and lung cancers.25,26 
Majority of the reports about the comparison of LS vs. OS have 
insisted the same trends, less complications whether they being 
intraoperative or postoperative and equivalent survivals.
LS is an inevitable trend in endometrial cancer treatment. 
However, it should be noted that LS must be performed only 
by qualified surgeons with enough experience to meet the 
general surgical adequacy.
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